Approval · Notice of Compliance 5127 · 1995
CELLCEPT: Notice of Compliance 5127
Issued November 15, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5127
- Date
- November 15, 1995
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Immunosuppressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELLCEPT | 02192748 | Marketed |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 250 MG per CAP